PVAM
Pacific View Asset Management Portfolio holdings
AUM
$20.8M
This Quarter Return
+5.69%
1 Year Return
+20.08%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$126M
AUM Growth
+$126M
(+22%)
Cap. Flow
+$18.9M
Cap. Flow
% of AUM
14.92%
Top 10 Holdings %
Top 10 Hldgs %
43.52%
Holding
125
New
18
Increased
44
Reduced
31
Closed
28
Top Buys
| 1 |
Granite Construction
GVA
|
$4.44M |
| 2 |
ARRY
Array Biopharma Inc
ARRY
|
$3.78M |
| 3 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$2.98M |
| 4 |
Pinnacle Financial Partners
PNFP
|
$2.33M |
| 5 |
AIMT
Aimmune Therapeutics, Inc.
AIMT
|
$2.3M |
Top Sells
| 1 |
Monro
MNRO
|
$2.43M |
| 2 |
Schneider National
SNDR
|
$1.89M |
| 3 |
ASXC
Asensus Surgical, Inc.
ASXC
|
$1.69M |
| 4 |
LHCG
LHC Group LLC
LHCG
|
$1.65M |
| 5 |
MXWL
Maxwell Technologies Inc
MXWL
|
$1.16M |
Sector Composition
| 1 | Industrials | 21.06% |
| 2 | Healthcare | 18.93% |
| 3 | Financials | 12.68% |
| 4 | Technology | 9.76% |
| 5 | Consumer Staples | 8.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Madrigal Pharmaceuticals
MDGL
$9.76B
| $360K | 0.29% | +1,287 | New | +$360K |
|
|
NUVA
77
DELISTED
NuVasive, Inc.
NUVA
| $358K | 0.28% | 6,878 +1,419 | +26% | +$73.9K |
|
78
Emcor
EME
$27.8B
| $349K | 0.28% | 4,598 -5 | -0.1% | -$380 |
|
79
Supernus Pharmaceuticals
SUPN
$2.53B
| $348K | 0.28% | +5,832 | New | +$348K |
|
80
Comfort Systems
FIX
$24.8B
| $344K | 0.27% | 7,513 -8,233 | -52% | -$377K |
|
81
Sarepta Therapeutics
SRPT
$1.78B
| $341K | 0.27% | 2,585 -241 | -9% | -$31.8K |
|
82
Amicus Therapeutics
FOLD
$2.34B
| $336K | 0.27% | +21,522 | New | +$336K |
|
|
BPMC
83
DELISTED
Blueprint Medicines
BPMC
| $307K | 0.24% | 4,830 +1,034 | +27% | +$65.7K |
|
84
PotlatchDeltic
PCH
$3.25B
| $298K | 0.24% | 5,867 -31 | -0.5% | -$1.58K |
|
85
ASGN Inc
ASGN
$2.38B
| $295K | 0.23% | 3,775 -4,362 | -54% | -$341K |
|
|
PFPT
86
DELISTED
Proofpoint, Inc.
PFPT
| $280K | 0.22% | 2,438 -13 | -0.5% | -$1.49K |
|
87
Ultragenyx Pharmaceutical
RARE
$2.89B
| $279K | 0.22% | +3,622 | New | +$279K |
|
88
Apogee Enterprises
APOG
$947M
| $275K | 0.22% | 5,693 -54 | -0.9% | -$2.61K |
|
|
CLVS
89
DELISTED
Clovis Oncology, Inc.
CLVS
| $269K | 0.21% | 5,935 +1,707 | +40% | +$77.4K |
|
90
Silicon Laboratories
SLAB
$4.41B
| $266K | 0.21% | 2,681 -18 | -0.7% | -$1.79K |
|
91
EastGroup Properties
EGP
$9.04B
| $259K | 0.21% | 2,714 -5,102 | -65% | -$487K |
|
92
FibroGen
FGEN
$47.8M
| $254K | 0.2% | +4,030 | New | +$254K |
|
93
Louisiana-Pacific
LPX
$6.62B
| $249K | 0.2% | 9,115 -1 | -0% | -$27 |
|
94
Salesforce
CRM
$245B
| $209K | 0.17% | +1,539 | New | +$209K |
|
|
MXWL
95
DELISTED
Maxwell Technologies Inc
MXWL
| $140K | 0.11% | 26,932 -223,068 | -89% | -$1.16M |
|
96
ACI Worldwide
ACIW
$5.09B
| – | – | -10,180 | Closed | -$241K |
|
97
AnaptysBio
ANAB
$569M
| – | – | -1,976 | Closed | -$205K |
|
98
Belden
BDC
$5.16B
| – | – | -3,746 | Closed | -$258K |
|
99
Commault Systems
CVLT
$8.3B
| – | – | -5,969 | Closed | -$341K |
|
100
Deluxe
DLX
$882M
| – | – | -4,762 | Closed | -$351K |
|